WomanCare Global Adds Conception Kit® to Product Portfolio
San Diego, CA — WomanCare Global announced the addition of the Conception Kit® to their comprehensive portfolio of high-quality, safe and affordable reproductive healthcare products. The Conception Kit® represents the first fertility product in the portfolio and will be available in the UK and other countries (excluding US and Canada).
Saundra Pelletier, Chief Executive Officer of WomanCare Global commented, “We’re excited about the addition of this product to our portfolio. The focus of our work is on empowering women to manage the full range of their reproductive health and family planning needs. With the Conception Kit®, we now offer women safe, high-quality and affordable products across the entire reproductive health continuum.”
“The Conception Kit® benefits couples who want to, but haven’t yet been able to conceive,” said Dr. Matthew Reeves, WomanCare Global’s Chief Medical Officer and Board Certified OB/GYN. “The Conception Kit® provides a cost-effective, at home option that can be used prior to more expensive and invasive fertility procedures.”
WomanCare Global secured rights to market the Conception Kit® outside of the United States from Conceivex Inc.
About WomanCare Global:
WomanCare Global improves the lives of women, their families, and communities, by enabling access to quality, affordable birth control and reproductive healthcare products. We believe that when women can choose whether and when they’ll have children, they can be at their best. The result is greater personal empowerment, flourishing families, prosperous communities, and for all of us, a better world. While serving women is the passion that drives what we do, it’s our business intelligence that makes our work possible. We strategically redirect revenue from developed countries to underserved markets. In this way, we eliminate economic and geographic barriers and increase our impact, reaching women no matter where they live, in more than 100 countries worldwide. WomanCare Global was founded by Ipas in 2009 and operates independently as a UK Registered Charity (No.1138896). For more information, please visit womancareglobal.org.
Conceivex, Inc. is a privately owned reproductive healthcare company headquartered in Western Michigan. The company developed and produced the Conception Cap® and the Conception Kit®. The Conception Kit® is FDA & CE approved.
VP, Corporate Communications